A Multicenter, Randomized, Double-Blind, Double Dummy, Parallel Group, Active-Controlled 8-Week Study To Evaluate The Effect Of Sacubitril And Valsartan (LCZ696) Versus Enalapril On Changes In Nt-ProbNP And Safety And Tolerability Of In-Hospital Initiation Of LCZ696 Compared To Enalapril In Hfref Patients Who Have Been Stabilized Following Hospitalization For Acute Decompensated Heart Failure (ADHF).
Principal Investigator(s)
Email for information
Funded by
GENEVA
Research Start Date
Status
Active
The Overall Study Sponsor has developed a study to evaluate the effect of sacubitril and valsartan (LCZ696) versus enalapril on changes in NT-proBNP and safety and tolerability of in-hospital initiation of sacubitril and valsartan compared to enalapril in HFrEF patients who have been stabilized following hospitalization for acute decompensated heart failure (ADHF).
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.